Work

Survival Advantage for Patients (pts) with Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) Treated with Imatinib.

Year: 2004

Type: article

Source: Blood

DOI: 10.1182/blood.v104.11.1006.1006

Authors: Jorge Cortes, Moshe Talpaz, Susan O’Brien, Guillermo Garcia-Manero, Farhad Ravandi-Kashami, Francis Giles, Stefan Faderl, William Wierda, Jianqin Shan, Mary Beth Rios, Hagop Kantarjian

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2536756763

FWCI:

Cites:

Cited by: 2

Related to: 10